Eledon Pharmaceuticals's total assets for Q3 2024 were $114.58M, a decrease of -4.90% from the previous quarter. ELDN total liabilities were $38.52M for the fiscal quarter, a -70.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.